Intra-Cellular Therapies (ITCI) Tops Q2 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. BIIB
7. CMG
8. TENB
9. KLAC
10. ETSY

Go back to Intra-Cellular Therapies (ITCI) Tops Q2 EPS by 11c

Intra-Cellular Therapies (ITCI) PT More Than Doubled at Cowen

August 6, 2015 8:14 AM EDT

Cowen analyst Ritu Baral sharply raised the price target on Outperform-rated Intra-Cellular Therapies (NASDAQ: ITCI) to $62.00 (from $29.00) ahead of the '007 Ph3 read-out.

The firm has increased conviction around the clinical success of the program. "We look forward for the first Ph3... More